Navigation Links
3SBio Inc. Announces Unaudited First Quarter 2012 Results
Date:5/13/2012

include, but may not be limited to, discussions and statements regarding: full year revenue target, business growth and prospects, product pricing trends, operation plans and objectives, market size or patient number or illness prevalence estimates, product development prospects, future pipeline progress, regulatory review, certification and approval prospects,  impact of the government policies and regulations, partnerships or collaborations and the outcome thereof, capital expense estimate, future operations and strategies. Forward-looking statements can be identified by such terminology as "believe," "expect," "plans," "strategy," "potential", "prospects," "forecast," "estimate," "project," "anticipate," "aim," "will" or "would", "may" or "might", and words, phrases, expressions, and usages of similar meaning or substance or the negative thereof.

Forward-looking statements are based on management's current assumptions, beliefs, expectations, and projections, in light of the information currently available, and actual results, performances, or achievements could differ materially from those implied or expressed by the forward-looking statements.  Among the factors that could cause actual results to differ from what the Company currently anticipates may include: regulatory actions such as adverse drug pricing adjustments, competition from other domestic and foreign pharmaceutical companies; risks and uncertainties related to cooperation, joint venture, and partnerships, including deal consummation risks; changes in China's healthcare insurance system; Chinese government policies and regulations; the segment market growth for our  products; market acceptance of our products; hospital or patient demand for our products; progress of our clinical trials; receipt and timing of regulatory approvals for new products and indications; our ability to enhance production, sales and distribution network and other aspects of operation; our ability to effec
'/>"/>

SOURCE 3SBio Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. 3SBio Inc. Files Annual Report on Form 20-F for Fiscal Year 2011
2. 3SBio Inc. to Present at the UBS Greater China Conference 2012
3. 3SBio Inc. Announces Results of 2011 Annual General Meeting
4. 3SBio Inc. Announces Unaudited First Quarter 2011 Results
5. 3SBio Inc. Schedules Unaudited First Quarter 2011 Results
6. 3SBio Inc. Schedules Unaudited Fourth Quarter and Fiscal Year 2010 Results
7. 3SBio Inc. Receives SFDA Approval for TPIAO Label Extension for the Treatment of ITP
8. 3SBio Inc. Announces Unaudited Third Quarter Results
9. 3SBio Inc. Announces Unaudited Second Quarter Results
10. 3SBio Inc. Schedules Second Quarter 2010 Unaudited Financial Results
11. 3SBio Inc. Announces Filing of Form 20-F With SEC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... , Aug. 27, 2015  Asterias Biotherapeutics, Inc. ... emerging field of regenerative medicine, today announced that executives ... in the month of September.  , ... at Rodman & Renshaw,s 17th Annual Global Investment Conference ... at the St. Regis Hotel in New ...
(Date:8/27/2015)... , August 27, 2015 GlassesOff (OTCBB: ... processing functions in the human vision system, announced today a ... point guard Chris Paul to develop a new ... want to improve their real-life on-court performance. Vision ... whether it is shooting a ball or blocking a pass. ...
(Date:8/27/2015)... , Aug. 27, 2015 In response ... FedEx, UPS and The US Postal Service to ... classified as ,select agents, by the CDC, Marken ... handling these sensitive shipments. Marken uses ... regulations, trained and certified personnel to ensure the ...
(Date:8/26/2015)... /PRNewswire/ - iCo Therapeutics ("iCo" or "the Company") (TSX-V: ... the quarter ended June 30, 2015. Amounts, unless ... presented under International Financial Reporting Standards ("IFRS"). ... our Oral Amp B program, rapidly advancing towards ... Andrew Rae , President & CEO of iCo ...
Breaking Biology Technology:Asterias Biotherapeutics to Present at Upcoming Investor Conferences 2Eight-Time All-Star Chris Paul and GlassesOff Partner to Develop Innovative Mobile App Designed to Improve On-Court Performance 2Eight-Time All-Star Chris Paul and GlassesOff Partner to Develop Innovative Mobile App Designed to Improve On-Court Performance 3Marken Ensures Safe Transportation Of Select Agents And Toxins 2iCo Therapeutics Announces Second Quarter 2015 Financial Results 2iCo Therapeutics Announces Second Quarter 2015 Financial Results 3
... Recently, as I sat at lunch sending off a series ... on how our professional lives continue to evolve dramatically, and ... CEO of a company that is driving the adoption of ... how quickly technological change continues to transform and enhance our ...
... issues going on right now, it could be helpful ... yesterday's critical moments. , ,There are many quotes ... are worth applying to your position in management, education, ... of things. That's very important in today's global economy. ...
... - Wisconsin-based high-tech startup and spin-off companies ... The most recent example of this is ... developing laboratory tools for analysis of cellular reprogramming ... targets, quantitative microarrays, and related products, will use ...
Cached Biology Technology:Visions: Rimas Buinevicius, CEO of Sonic Foundry 2Visions: Rimas Buinevicius, CEO of Sonic Foundry 3Business leaders can learn from historical insights 2Business leaders can learn from historical insights 3Business leaders can learn from historical insights 4Business leaders can learn from historical insights 5Wisconsin start up Primorigen Biosciences corrals out-of-state investment 2
(Date:8/6/2015)... and TELTOW, Germany , August 6, ... Conference, SensoMotoric Instruments (SMI) shows the world,s ... , based on Epson,s Moverio BT-200 see-through head ... With this new solution, unprecedented quality and efficiency is ... with context-sensitive displays. For the first time, professionals and ...
(Date:8/4/2015)... DUBLIN , Aug. 04, 2015 /PRNewswire/ ... ( http://www.researchandmarkets.com/research/nvh7k2/digital_forensics ) has announced the addition ... Component (Hardware, Software, and Service), Sub-Segment (Computer ... Cloud Forensics), Tool Types, Service, Vertical and ... report to their offering. By ...
(Date:7/31/2015)... julho de 2015 A 10 a. ... realizada pela BGI de 22-25 de outubro de 2015, em ... A conferência está celebrando seu 10 o. aniversário este ... tornou uma das reuniões mais influentes do mundo no ... dinâmicos, entusiastas e prazerosos. A ICG-10 ...
Breaking Biology News(10 mins):SMI Shows First Eye Tracking Upgrade for Augmented Reality Glasses 2SMI Shows First Eye Tracking Upgrade for Augmented Reality Glasses 3Digital Forensics Market - The Market Represents a Compound Annual Growth Rate (CAGR) of 11.3% From 2015 to 2020 2A 10a. Conferência Internacional sobre Genômica (ICG-10) será em outubro 2A 10a. Conferência Internacional sobre Genômica (ICG-10) será em outubro 3
... The Sainsbury Laboratory, and Virginia Polytechnic Institute and State ... plant disease causing organism revealing that it acts like ... uncovered the tactics used to sneak past the plant,s ... researchers to identify the components of the plant immune ...
... New research suggests that private industry and academic science ... two can still be complementary. Over the past ... has risen steadily. That has led to concerns about ... of Chicago sociologist James Evans finds that industry can ...
... A myriad of inputs can indicate a body,s health ... consider all signals and "decide" when and how much ... for example. Reporting in Nature Chemical Biology ... of Medicine have teased out how these cells interpret ...
Cached Biology News:Plant disease 'stealth bomber' tactics subverted to tackle hundreds of plant pathogens 2Plant disease 'stealth bomber' tactics subverted to tackle hundreds of plant pathogens 3Industry collaboration enhances academic science, sociologist finds 2On...off...on...off... The circuitry of insulin-releasing cells 2On...off...on...off... The circuitry of insulin-releasing cells 3
... Reagent, 1 ml. Improves reproducibility ... by preventing streaking.Eliminates extra spots ... proteins.Stabilizes proteins throughout entire 2-D ... protein patterns.Ideal for both analytical ...
... offers major advantages over other RNA precipitation methods ... or carbohydrates. It is the method of choice ... from RNA preparations. Note, LiCl precipitation may not ... If the RNA is to be used for ...
LIVE/DEAD® Sperm Viability Kit *200-1000 assays*...
Human Xg Affinity Purified Polyclonal Ab Keywords: Xg glycoprotein, hereditary hemorrhagic telangiectasia Protein Family: ...
Biology Products: